PHARMA

PHARMA

Pharmaceutical Hydrogenation Membrane in Indonesia

Catalytic hydrogenation is a critical step in active pharmaceutical ingredient (API) synthesis. Indonesia's massive nickel processing industry and geothermal/solar resources create a natural opportunity for green hydrogen.

Market Context

Indonesia

Policy

National Energy Transition Plan

H₂ Target

Green hydrogen for nickel and industrial decarbonization

1

Cities

4

Industries

Ultra-Clean Hydrogen Source

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

GMP-Compatible On-Site Generation

On-site electrolysis provides a controlled, traceable hydrogen source that simplifies GMP documentation and qualification versus multi-sourced delivered gas.

Batch-Flexible Operation

Pharmaceutical manufacturing operates in batches. IONZERA's high wettability supports start-stop operation, generating hydrogen only when hydrogenation reactors require it.

Pharmaceutical Hydrogenation in Indonesia’s Hydrogen Market

Indonesia's massive nickel processing industry and geothermal/solar resources create a natural opportunity for green hydrogen. The country's industrial base in Java and Sulawesi drives early hydrogen demand.

IONZERA offers Indonesian industrial projects competitive pricing and fast delivery from India, supporting the country's early green hydrogen initiatives.

Nickel ProcessingRefiningGeothermal-to-H2Fertilizer
3x

Lower Resistance

20%

Thinner Profile

PERFORMANCE ADVANTAGE

Why IONZERA for Pharmaceutical Hydrogenation in Indonesia

Electrolytic hydrogen from water splitting is inherently free of carbon monoxide, sulfur, and hydrocarbon impurities that can poison precious metal hydrogenation catalysts used in API manufacturing.

Shipping & Logistics

Air freight from India to Jakarta in 3-5 business days.

Area Resistance

3x LOWER
Area Specific Resistance ComparisonIONZERA0.09-0.1 Ω·cm²Zirfon0.30 Ω·cm²00.10.20.3 Ω·cm²~3x Lower

Thickness

20% THINNER
Membrane Thickness ComparisonIONZERA350-410 μmZirfon500 μm500 μm scale20-30%thinnerThinner membrane = More compact stacks= Higher power density

Pharmaceutical Hydrogenation Membrane in Indonesia Cities

Frequently Asked Questions

Why choose IONZERA for pharmaceutical hydrogenation in Indonesia?

IONZERA delivers 3x lower ionic resistance than Zirfon, making it ideal for pharmaceutical hydrogenation applications in Indonesia. IONZERA offers Indonesian industrial projects competitive pricing and fast delivery from India, supporting the country's early green hydrogen initiatives.

How can IONZERA support nickel processing decarbonization in Indonesia?

IONZERA membranes enable efficient on-site hydrogen production that can replace fossil-derived hydrogen in nickel processing operations, supporting Indonesia's industrial decarbonization goals.

Ready to Start

Request Pharmaceutical Hydrogenation Samples for Indonesia

Contact G-Hexa for IONZERA pharmaceutical hydrogenation membrane samples, technical specifications, and volume pricing for Indonesia-based projects.

Request Sample